SCHEMBL569712

SCHEMBL569712

CCN(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6177026 0.97
SCHEMBL27792508 0.89 FFAR3 (0.30)
SCHEMBL4173859 0.87 ALOX15 (0.37)
SCHEMBL3247565 0.82
Toluene SCHEMBL11338240 0.80 TSHR (0.44)
SCHEMBL30779731 0.77 GAA (0.35)
SCHEMBL4438789 0.77
SCHEMBL1512269 0.77
SCHEMBL1163352 0.75
SCHEMBL10669462 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626115-B2 Fused pyrimidinone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents UNIVERSITE DE NANTES (FR) 2020-04-21 US claimed
EP-2813515-B1 TRANSDERMALLY DELIVERED HYALURONIC ACID-PROTEIN CONJUGATE PHI BIOMED CO LTD (KR) 2019-07-10 EP claimed
US-20190002467-A1 NOVEL FUSED PYRIMIDINONE AND TRIAZINONE DERIVATIVES CONTAINING BRIDGED NITROGEN, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES AS ANTIFUNGAL AND/OR ANTIPARASITIC AGENTS UNIVERSITE DE NANTES (FR) 2019-01-03 US claimed
US-20180221366-A1 METHODS AND COMPOSITIONS USEFUL FOR TREATING DISEASES INVOLVING BCL-2 FAMILY PROTEINS WITH QUINOLINE DERIVATIVES EUTROPICS PHARMACEUTICALS, INC. 2018-08-09 US claimed
US-20180200262-A1 TARGETED NOTCH PATHWAY INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2018-07-19 US claimed
CN-108290962-A NCC films and product based on NCC films 美罗迪亚有限公司 2018-07-17 CN claimed
EP-3328862-A1 NOVEL FUSED PYRIMIDINONE AND TRIAZINONE DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES AS ANTIFUNGAL AND/OR ANTIPARASITIC AGENTS. Universite de Nantes (FR) 2018-06-06 EP claimed
EP-3307721-A1 TARGETED NOTCH PATHWAY INHIBITORS H. Hoffnabb-La Roche Ag (CH) 2018-04-18 EP claimed
CN-107438599-A TARGETED NOTCH PATHWAY INHIBITORS 豪夫迈·罗氏有限公司 2017-12-05 CN claimed
WO-2017020944-A1 NOVEL FUSED PYRIMIDINONE AND TRIAZINONE DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES AS ANTIFUNGAL AND/OR ANTIPARASITIC AGENTS UNIVERSITE DE NANTES (FR) 2017-02-09 WO claimed
US-20050255047-A1 Smoke composition L. C. B. (FR) 2005-11-17 US claimed
EP-0647884-B1 Photoresist strippers containing reducing agents to reduce metal corrosion MALLINCKRODT BAKER INC (US) 1998-04-08 EP claimed
EP-0202095-B1 PROCESS FOR PREPARING 6-AMINO-3-HYDRAZINOPYRIDAZINE DERIVATIVES I.S.F. Socièta per Azioni (IT) 1991-04-03 EP claimed
EP-0123066-B1 REACTION OF CARBONYLHYDRAZINES AND ORGANIC PEROXIDES TO FOAM UNSATURATED POLYESTER RESINS PENNWALT CORPORATION (US) 1988-10-12 EP claimed
US-4692269-A BLOWING AGENTS; CLOSED-CELL FOAMS PENNWALT CORPORATION (US) 1987-09-08 US claimed
EP-0220751-A2 Foamable and cross-linkable unsaturated polyester composition PENNWALT CORPORATION (US) 1987-05-06 EP claimed
EP-0220364-A2 Reaction of certain hydrazide compounds with free radical initiators to produce crosslinked polymer foams PENNWALT CORPORATION (US) 1987-05-06 EP claimed
EP-0219595-A2 A gas-realising composition for tailoring gas evolution of system PENNWALT CORPORATION (US) 1987-04-29 EP claimed
US-4636528-A Foaming of unsaturated polyester resin at elevated temperatures PENNWALT CORPORATION (US) 1987-01-13 US claimed
US-4607060-A FREE RADICAL CATALYSIS PENNWALT CORPORATION (US) 1986-08-19 US claimed